Unique ID issued by UMIN | UMIN000013225 |
---|---|
Receipt number | R000015221 |
Scientific Title | The study of composite skin grafting over human acellular dermal matrix scaffold for treating diabetic low extremity ulcers |
Date of disclosure of the study information | 2014/02/22 |
Last modified on | 2014/02/22 16:25:16 |
The study of composite skin grafting over human acellular dermal matrix scaffold for treating diabetic low extremity ulcers
composite skin grafting for diabetic low extremity ulcers
The study of composite skin grafting over human acellular dermal matrix scaffold for treating diabetic low extremity ulcers
composite skin grafting for diabetic low extremity ulcers
Asia(except Japan) |
Diabetic low extremity ulcer is one of the refractory wounds and always poses therapeutic challenges.
Dermatology | Plastic surgery | Adult |
Child |
Others
NO
Diabetic low extremity ulcer is one of the refractory wounds and always poses therapeutic challenges. The use of composite razor-thin skin grafting over acellular dermal matrix scaffold has been successful for burns but rarely been reported in treating diabetic low extremity ulcers. Here, we investigated the outcomes of composite razor-thin skin autografting over acellular dermal matrix scaffold on diabetic low extremity ulcers treatment.
Safety,Efficacy
Others
Others
Not applicable
Effectiveness
safety
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
Active
2
Treatment
Medicine |
patients received a split-thickness autograft combined with ReCell(experimental group)
patients received split-thickness autograft alone (control group)
18 | years-old | <= |
Not applicable |
Male and Female
Patients aged over eighteen years old with a diagnosis of type 1 or type 2 diabetes, who had a diabetic low extremity ulcer last for over four weeks, with a stage 2 by Wagner's scale, and size more than three cm2, absence of vascular reconstruction (ankle brachial indices between 0.7 and 1.2) and had indications of skin grafting were eligible for inclusion
patients with medical conditions that would impair wound healing (e.g. malignancy, autoimmune disease), using corticosteroids or immunosuppressor, a high anesthesiology or surgical risk, uncontrolled hyperglycemia (preoperative HbA1c greater than 12%)
80
1st name | |
Middle name | |
Last name | Zhicheng Hu |
The First Affiliated Hospital of Sun Yat-sen University
Department of Burn Surgery
58 Zhongshan Road II, Guangzhou 510080, China
+86-20-87755766-8235
willway128@163.com
1st name | |
Middle name | |
Last name | Zhicheng Hu |
The First Affiliated Hospital of Sun Yat-sen University
Department of Burn Surgery
58 Zhongshan Road II, Guangzhou 510080, China
+86-20-87755766-8235
willway128@163.com
Department of Burn Surgery
The First Affiliated Hospital of Sun Yat-sen University
National Natural Science Foundation of China (30973128, 81272096)
Sun Yat-sen University Clinical Research 5010 Program (2013001)
Other
NO
2014 | Year | 02 | Month | 22 | Day |
Unpublished
Completed
2010 | Year | 09 | Month | 01 | Day |
2010 | Year | 09 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2014 | Year | 01 | Month | 31 | Day |
2014 | Year | 02 | Month | 22 | Day |
2014 | Year | 02 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015221
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |